Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” but because its scope fundamentally changes how organizations must recruit, ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

Life sciences industry has regulatory compliance at the center of all its operations, so maintaining the integrity of data has always been a pressing need for this industry globally. Regulators such ...

Disruptions, whether positive, like the addition of new data sources, or challenging, such as supplier exits, are part of the natural evolution of open claims. Specific changes, such as expanded ...

DUBLIN--(BUSINESS WIRE)--The "Efficient Batch Record Design and Review" training has been added to ResearchAndMarkets.com's offering. This online training is designed for professionals in the ...

For more than 25 years, my work has revolved around one guiding principle: quality. In the life sciences sector, safeguarding data integrity, compliance and ethical practices has never been optional.